Abvc Biopharma (ABVC) Change in Accured Expenses (2010 - 2026)
Abvc Biopharma (ABVC) posted Change in Accured Expenses of $45,663 for Q2 2026, compared with -$16,865 a year earlier.
Powered by 
Analysis
Abvc Biopharma (ABVC) Change in Accured Expenses (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Abvc Biopharma was $167,357, up 77.7% year-over-year; for FY2025, it was $152,207, down 0.4% from FY2024.
- Annual Change in Accured Expenses has declined for three consecutive years.
- In prior years, Abvc Biopharma's Change in Accured Expenses was $152,819 in FY2024 (-76.1%), $638,762 in FY2023 (-60.3%), $1.61 million in FY2022 and -$173,151 in FY2021.
- Quarterly Change in Accured Expenses has run from a low of -$540,519 in Q3 2021 to a high of $1.71 million in Q4 2022 over five years.
- According to Business Quant data, Change in Accured Expenses for the three prior quarters was -$7,265 (Q1 2026), $162,591 (Q4 2025) and -$33,632 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Abvc Biopharma | 26.03 Mn | 28.01 Mn | - | 45,663.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45,663.00 |
| Mar 31, 2026 | -7,265.00 |
| Dec 31, 2025 | 162,591.00 |
| Sep 30, 2025 | -33,632.00 |
| Jun 30, 2025 | -16,865.00 |
| Mar 31, 2025 | 40,113.00 |
| Dec 31, 2024 | 110,870.00 |
| Sep 30, 2024 | -39,949.00 |
| Jun 30, 2024 | 125,503.00 |
| Mar 31, 2024 | -43,605.00 |
| Dec 31, 2023 | -9,864.00 |
| Sep 30, 2023 | 116,848.00 |
| Jun 30, 2023 | 678,094.00 |
| Mar 31, 2023 | -146,316.00 |
| Dec 31, 2022 | 1.71 Mn |
| Sep 30, 2022 | -77,391.00 |
| Jun 30, 2022 | 91,377.00 |
| Mar 31, 2022 | -113,292.00 |
| Dec 31, 2021 | 165,777.00 |
| Sep 30, 2021 | -540,519.00 |
API Access
Abvc Biopharma Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();